Expansion of gd T cells in patients infected with cutaneous leishmaniasis with and without glucantime therapy
Autor(a) principal: | |
---|---|
Data de Publicação: | 2002 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Infectious Diseases |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702002000500007 |
Resumo: | The expansion of <FONT FACE=Symbol>gd </font>T cells in patients with active cutaneous leishmaniasis, with or without glucantime therapy, was investigated. Twenty patients with local cutaneous leishmaniasis including glucantime-treated (n=10) and untreated (n=10) patients were selected. The controls were healthy individuals (n=10) living in endemic areas. Whole blood was obtained and the T cell subpopulations were analyzed by flow cytometry. Significantly more <FONT FACE=Symbol>gd</FONT> CD3+ T cells were observed in untreated patients (15.9% ± 5.9), when compared with glucantime-treated patients (4.6% ± 1.4) and controls (5.3% ± 2.3). On the other hand, when the percentages of ab CD3+ T-cells were analyzed different results were obtained. A significant increase in <FONT FACE=Symbol>ab</FONT> T cells was seen in glucantime-treated patients (62.4% ± 7.6), when compared to the untreated patients (55.7% ± 5.5) and controls (55.1% ± 9.6). The percentage of total CD3+ T cells was statistically greater in both glucantime-treated (68.8% ± 7.4) and untreated patients (73.4% ± 5.9) when compared to the controls (61% ± 10.3). These results are consistent with previous results on the expansion of <FONT FACE=Symbol>gd</FONT>T cells during the course of cutaneous leishmaniasis. They also indicate that glucantime therapy can reverse the expansion of <FONT FACE=Symbol>gd</FONT>T cells and as a result increase the percentages of <FONT FACE=Symbol>ab</FONT> CD3+ T cells. |
id |
BSID-1_79269dea017046996c22d423d7dacde6 |
---|---|
oai_identifier_str |
oai:scielo:S1413-86702002000500007 |
network_acronym_str |
BSID-1 |
network_name_str |
Brazilian Journal of Infectious Diseases |
repository_id_str |
|
spelling |
Expansion of gd T cells in patients infected with cutaneous leishmaniasis with and without glucantime therapyCutaneous leishmaniasisgamma-delta T cellsglucatime therapyThe expansion of <FONT FACE=Symbol>gd </font>T cells in patients with active cutaneous leishmaniasis, with or without glucantime therapy, was investigated. Twenty patients with local cutaneous leishmaniasis including glucantime-treated (n=10) and untreated (n=10) patients were selected. The controls were healthy individuals (n=10) living in endemic areas. Whole blood was obtained and the T cell subpopulations were analyzed by flow cytometry. Significantly more <FONT FACE=Symbol>gd</FONT> CD3+ T cells were observed in untreated patients (15.9% ± 5.9), when compared with glucantime-treated patients (4.6% ± 1.4) and controls (5.3% ± 2.3). On the other hand, when the percentages of ab CD3+ T-cells were analyzed different results were obtained. A significant increase in <FONT FACE=Symbol>ab</FONT> T cells was seen in glucantime-treated patients (62.4% ± 7.6), when compared to the untreated patients (55.7% ± 5.5) and controls (55.1% ± 9.6). The percentage of total CD3+ T cells was statistically greater in both glucantime-treated (68.8% ± 7.4) and untreated patients (73.4% ± 5.9) when compared to the controls (61% ± 10.3). These results are consistent with previous results on the expansion of <FONT FACE=Symbol>gd</FONT>T cells during the course of cutaneous leishmaniasis. They also indicate that glucantime therapy can reverse the expansion of <FONT FACE=Symbol>gd</FONT>T cells and as a result increase the percentages of <FONT FACE=Symbol>ab</FONT> CD3+ T cells.Brazilian Society of Infectious Diseases2002-10-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702002000500007Brazilian Journal of Infectious Diseases v.6 n.5 2002reponame:Brazilian Journal of Infectious Diseasesinstname:Brazilian Society of Infectious Diseases (BSID)instacron:BSID10.1590/S1413-86702002000500007info:eu-repo/semantics/openAccessDarabi,HaidehAbolhassani,MohsenKariminia,AminaAlimohammadian,Mohammad H.eng2003-07-15T00:00:00Zoai:scielo:S1413-86702002000500007Revistahttps://www.bjid.org.br/https://old.scielo.br/oai/scielo-oai.phpbjid@bjid.org.br||lgoldani@ufrgs.br1678-43911413-8670opendoar:2003-07-15T00:00Brazilian Journal of Infectious Diseases - Brazilian Society of Infectious Diseases (BSID)false |
dc.title.none.fl_str_mv |
Expansion of gd T cells in patients infected with cutaneous leishmaniasis with and without glucantime therapy |
title |
Expansion of gd T cells in patients infected with cutaneous leishmaniasis with and without glucantime therapy |
spellingShingle |
Expansion of gd T cells in patients infected with cutaneous leishmaniasis with and without glucantime therapy Darabi,Haideh Cutaneous leishmaniasis gamma-delta T cells glucatime therapy |
title_short |
Expansion of gd T cells in patients infected with cutaneous leishmaniasis with and without glucantime therapy |
title_full |
Expansion of gd T cells in patients infected with cutaneous leishmaniasis with and without glucantime therapy |
title_fullStr |
Expansion of gd T cells in patients infected with cutaneous leishmaniasis with and without glucantime therapy |
title_full_unstemmed |
Expansion of gd T cells in patients infected with cutaneous leishmaniasis with and without glucantime therapy |
title_sort |
Expansion of gd T cells in patients infected with cutaneous leishmaniasis with and without glucantime therapy |
author |
Darabi,Haideh |
author_facet |
Darabi,Haideh Abolhassani,Mohsen Kariminia,Amina Alimohammadian,Mohammad H. |
author_role |
author |
author2 |
Abolhassani,Mohsen Kariminia,Amina Alimohammadian,Mohammad H. |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Darabi,Haideh Abolhassani,Mohsen Kariminia,Amina Alimohammadian,Mohammad H. |
dc.subject.por.fl_str_mv |
Cutaneous leishmaniasis gamma-delta T cells glucatime therapy |
topic |
Cutaneous leishmaniasis gamma-delta T cells glucatime therapy |
description |
The expansion of <FONT FACE=Symbol>gd </font>T cells in patients with active cutaneous leishmaniasis, with or without glucantime therapy, was investigated. Twenty patients with local cutaneous leishmaniasis including glucantime-treated (n=10) and untreated (n=10) patients were selected. The controls were healthy individuals (n=10) living in endemic areas. Whole blood was obtained and the T cell subpopulations were analyzed by flow cytometry. Significantly more <FONT FACE=Symbol>gd</FONT> CD3+ T cells were observed in untreated patients (15.9% ± 5.9), when compared with glucantime-treated patients (4.6% ± 1.4) and controls (5.3% ± 2.3). On the other hand, when the percentages of ab CD3+ T-cells were analyzed different results were obtained. A significant increase in <FONT FACE=Symbol>ab</FONT> T cells was seen in glucantime-treated patients (62.4% ± 7.6), when compared to the untreated patients (55.7% ± 5.5) and controls (55.1% ± 9.6). The percentage of total CD3+ T cells was statistically greater in both glucantime-treated (68.8% ± 7.4) and untreated patients (73.4% ± 5.9) when compared to the controls (61% ± 10.3). These results are consistent with previous results on the expansion of <FONT FACE=Symbol>gd</FONT>T cells during the course of cutaneous leishmaniasis. They also indicate that glucantime therapy can reverse the expansion of <FONT FACE=Symbol>gd</FONT>T cells and as a result increase the percentages of <FONT FACE=Symbol>ab</FONT> CD3+ T cells. |
publishDate |
2002 |
dc.date.none.fl_str_mv |
2002-10-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702002000500007 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702002000500007 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/S1413-86702002000500007 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Brazilian Society of Infectious Diseases |
publisher.none.fl_str_mv |
Brazilian Society of Infectious Diseases |
dc.source.none.fl_str_mv |
Brazilian Journal of Infectious Diseases v.6 n.5 2002 reponame:Brazilian Journal of Infectious Diseases instname:Brazilian Society of Infectious Diseases (BSID) instacron:BSID |
instname_str |
Brazilian Society of Infectious Diseases (BSID) |
instacron_str |
BSID |
institution |
BSID |
reponame_str |
Brazilian Journal of Infectious Diseases |
collection |
Brazilian Journal of Infectious Diseases |
repository.name.fl_str_mv |
Brazilian Journal of Infectious Diseases - Brazilian Society of Infectious Diseases (BSID) |
repository.mail.fl_str_mv |
bjid@bjid.org.br||lgoldani@ufrgs.br |
_version_ |
1754209238304948224 |